Abeona Therapeutics Inc.
ABEONASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $245.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.00$7.65
- Volume (live)
- -
- Avg. volume (3M)
- 1.30M
Abeona Therapeutics (ABEO) Stock Price & Financial Analysis
Abeona Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.30 - $4.50 |
|---|---|
| 52-Week High | $7.65 |
| 52-Week Low | $4.00 |
| Open | $4.33 |
| Volume (last close) | 663.68K |
| Average Volume (3M) | 1.30M |
| Revenue (TTM) | 25.52M |
|---|---|
| Net Income (TTM) | -62.89M |
| Free Cash Flow (TTM) | -81.53M |
| EPS (TTM) | −$1.07 |
| Profit Margin | -246.42% |
| Operating Margin | -327.64% |
| Return on Equity (ROE) | -49.11% |
| Debt to Equity | 0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Mar 31, 2000 |
| Market Cap | 245.88M |
|---|---|
| Shares Outstanding | 57.05M |
| Price to Sales (P/S) | 9.63 |
| Price to Book (P/B) | 1.92 |
| EV/EBITDA | -3.00 |
| 50-Day MA | $5.56 |
|---|---|
| 200-Day MA | $5.52 |
| 1-Year Change | −17.53% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
Abeona Therapeutics at a Glance
As of the Oct 27, 2026 close, Abeona Therapeutics (ABEO) has a market capitalization of $245.88M. The stock trades at 9.6× sales. Over the trailing twelve months it lost $62.89M on revenue of $25.52M and burned $81.53M of free cash flow. Revenue grew 6280.0% year over year.
As of its latest reported balance sheet, it holds $56.23M in cash and securities against $14.99M of debt, a net cash position of $41.24M.
Abeona Therapeutics does not currently pay a dividend.
The share price is down 17.5% over the past year. At $4.45 (the Oct 27, 2026 close) it sits near the bottom of its 52-week range of $4.00 to $7.65, below its 200-day moving average of $5.52.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $22.00, 394.4% above the Oct 27, 2026 close.
Frequently Asked Questions About Abeona Therapeutics
What is the current stock price for ABEO?
As of the Oct 27, 2026 close, ABEO stock trades at $4.45. The 52-week range is $4.00–$7.65, with a day range of $4.30–$4.50.
What is the P/E ratio for ABEO?
The P/E ratio (Price-to-Earnings) for ABEO is shown in the Key Statistics section. This valuation metric helps compare Abeona Therapeutics Inc. to industry peers.
Does ABEO pay dividends?
Abeona Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABEO?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for ABEO is Buy. The average 12-month price target is $22.00, a 394.4% upside from the Oct 27, 2026 close of $4.45.
What is the market cap of ABEO?
As of the Oct 27, 2026 close, Abeona Therapeutics's market capitalization is $253.9M, classifying it as a micro-cap company. Abeona Therapeutics operates in the Healthcare sector within the Biotechnology industry.